1. (1) Keys A: Coronary heart disease in seven countries (AHA Monograph No 29). Circulation, 41 (Suppl 1): 1-211, 1970
2. (2) Age standardized death rate for selected causes, by sex, latest available year. World Health Statistics Annuals, World Health Organization, 1970-1986
3. (3) Ueshima H: Follow-up study from the National Survey of Circulatory Disorders in Japan 1980. National Integrated Project for Prospective Observation of Non-communicable Disease and its Trends in the Aged (NIPPON DATA). J Jap Assoc Cerebro-cardiovascul Dis Control, 31: 231-237, 1997 (In Japanese)
4. (4) Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H, and The J-LIT Study Group: The influence of hypercholesterolemia on the occurrence of myocardial infarction in 47, 294 Japanese hypercholesterolemic population with no prior coronary artery disease: Primary prevention in the J-LIT Study. reported at the 2001 Annual Scientific Meeting of ACC (March 19, 2001, abstract: J Am Coll Cardiol 37, No. 2, Suppl A, abstract No. 842-6)
5. (5) Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop JH, and Packard CJ for the West of Scotland Coronary Prevention Study Group: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med, 333: 1301-1307, 1995